Geert Cauwenbergh - Net Worth and Insider Trading

Geert Cauwenbergh Net Worth

The estimated net worth of Geert Cauwenbergh is at least $5 dollars as of 2024-11-29. Geert Cauwenbergh is the President & CEO of Phio Pharmaceuticals Corp and owns about 2 shares of Phio Pharmaceuticals Corp (PHIO) stock worth over $5. Details can be seen in Geert Cauwenbergh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Geert Cauwenbergh has not made any transactions after 2017-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Geert Cauwenbergh

To

Geert Cauwenbergh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Geert Cauwenbergh owns 3 companies in total, including Phio Pharmaceuticals Corp (PHIO) , DARA Biosciences Inc (DARA) , and CalEthos Inc (GEDC) .

Click here to see the complete history of Geert Cauwenbergh’s form 4 insider trades.

Insider Ownership Summary of Geert Cauwenbergh

Ticker Comapny Transaction Date Type of Owner
PHIO Phio Pharmaceuticals Corp 2017-10-02 director & President and CEO
DARA DARA Biosciences Inc 2009-01-08 director
GEDC CalEthos Inc 2008-04-03 director

Geert Cauwenbergh Latest Holdings Summary

Geert Cauwenbergh currently owns a total of 1 stock. Geert Cauwenbergh owns 2 shares of Phio Pharmaceuticals Corp (PHIO) as of October 2, 2017, with a value of $5.

Latest Holdings of Geert Cauwenbergh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PHIO Phio Pharmaceuticals Corp 2017-10-02 2 2.72 5

Holding Weightings of Geert Cauwenbergh


Geert Cauwenbergh Form 4 Trading Tracker

According to the SEC Form 4 filings, Geert Cauwenbergh has made a total of 0 transactions in Phio Pharmaceuticals Corp (PHIO) over the past 5 years. The most-recent trade in Phio Pharmaceuticals Corp is the acquisition of 0 shares on October 2, 2017, which cost Geert Cauwenbergh around $4,500.

Insider Trading History of Geert Cauwenbergh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Geert Cauwenbergh Trading Performance

GuruFocus tracks the stock performance after each of Geert Cauwenbergh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geert Cauwenbergh is -12.57%. GuruFocus also compares Geert Cauwenbergh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geert Cauwenbergh within 3 months outperforms 5 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Geert Cauwenbergh's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Geert Cauwenbergh

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 21 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.79 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.23 LIMIT LIMIT LIMIT LIMIT LIMIT

Geert Cauwenbergh Ownership Network

Ownership Network List of Geert Cauwenbergh

No Data

Ownership Network Relation of Geert Cauwenbergh

Insider Network Chart

Geert Cauwenbergh Owned Company Details

What does Phio Pharmaceuticals Corp do?

Who are the key executives at Phio Pharmaceuticals Corp?

Geert Cauwenbergh is the director & President and CEO of Phio Pharmaceuticals Corp. Other key executives at Phio Pharmaceuticals Corp include Chief Development Officer Gerrit Dispersyn , Chief Development Officer John A Barrett , and Chief Business Officer Alexey Eliseev .

Phio Pharmaceuticals Corp (PHIO) Insider Trades Summary

Over the past 18 months, Geert Cauwenbergh made no insider transaction in Phio Pharmaceuticals Corp (PHIO). Other recent insider transactions involving Phio Pharmaceuticals Corp (PHIO) include a net purchase of 6,500 shares made by Robert J Bitterman , and a net purchase of 2,000 shares made by Robert L Ferrara .

In summary, during the past 3 months, insiders sold 0 shares of Phio Pharmaceuticals Corp (PHIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Phio Pharmaceuticals Corp (PHIO) were sold and 944 shares were bought by its insiders, resulting in a net purchase of 944 shares.

Phio Pharmaceuticals Corp (PHIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Phio Pharmaceuticals Corp Insider Transactions

No Available Data

Geert Cauwenbergh Mailing Address

Above is the net worth, insider trading, and ownership report for Geert Cauwenbergh. You might contact Geert Cauwenbergh via mailing address: 1 Stults Drive, Plainsboro Nj 08536.

Discussions on Geert Cauwenbergh

No discussions yet.